Navigation Links
Scientists Discover Prostate Cancer Triggering Molecule

Researchers at the University of North Carolina at Chapel Hill have discovered a molecule that triggers aggressive prostate tumors. The molecule//, labeled as Ack1is a part of the tyrosine kinase gene family and triggers aggressiveness in prostate tumors by messing up with their signals and directing cells to dump a tumor-suppressor protein.

This protein usually fights cancer growth by signaling that the cell destroy itself. Researchers say that Ack1 could be a new target for drug companies to target anti-cancer drugs. 'It's a remarkable effect. Tumors grew more rapidly and invaded as if they were converted to advanced prostate cancer,' said Dr. Shelton Earp, director of the UNC Lineberger Comprehensive Cancer Center and lead author of the study. It was found that in experimental systems Ack1 had a significant role in promoting tumor growth. The study also found that a drug developed by the National Cancer Institute was able to inhibit the growth of Ack1. The drug called geldanamycin inhibited Ack1 through interference with its molecular interactions, 'If you add geldanamycin to the prostate cancer cell, the drug knocks Hsp90 off oncogenic signaling molecules. This dramatically decreases Ack1 activity and slows tumor formation,' Earp added. The team also found that Ack1 levels were much higher in benign prostatic hypertrophy, or non-cancerous prostate enlargement than in advanced prostate cancer. "Because we found Ack1 is more active in advanced prostate tumors, and its inhibition blocks experimental tumor growth, we believe Ack1 should be a target for novel drug development," the researchers concluded in the study, the report of which is published in the November 15 issue of the journal Cancer Research.

Contact:
L. H. Lang
llang@med.unc.edu
919-843-9687
University of North Carolina School of Medicine

'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is ... software, The Guard®, has helped another long-time client pass their Department of Health ... satisfy the law. , Thanks to the help of the Compliancy Group's Audit ...
(Date:9/20/2017)... ... September 20, 2017 , ... The Centers for Medicare ... Rule that it will transition to using only Worksheet S-10 to distribute Disproportionate Share ... of three live 60-minute complimentary webinars on October 17, 2017 at 2 ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... for overcoming addiction. “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the ... extensive background in the field of addiction and homeless services, including more than ...
(Date:9/20/2017)... ... ... “The Foggy Road to Moorwick”: the adventures of a young Scottish girl yearning to see ... Liston, a busy mother of five who used her time waiting for children to finish ... over twenty years. It was a way to give some meaning to the hours ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians ... include Brevard’s own Ross A. Clevens, MD, FACS . The founder and medical ... Plastic and Reconstructive Surgeon who trained at Yale, Harvard and the University of Michigan. ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)...  Bayer will present the latest research from across its ... (ESMO) 2017 Congress, September 8-12 in Madrid, Spain ... clinical data on Bayer,s marketed portfolio and late-stage compounds as ... "We value the opportunity to ... at ESMO," said Carsten Brunn , Head of Pharmaceuticals, ...
(Date:8/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will present ... 11, 2017, in New York . ... scheduled to present at 11:05 a.m. Eastern Time. ... http://ir.hill-rom.com/events.cfm . A recorded replay will be available one hour ... 2017. About Hill-Rom ...
Breaking Medicine Technology: